D. E. Shaw & Co. Inc. Acquires New Position in Option Care Health, Inc. (NASDAQ:OPCH)

D. E. Shaw & Co. Inc. acquired a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 200,751 shares of the company's stock, valued at approximately $4,657,000. D. E. Shaw & Co. Inc. owned approximately 0.12% of Option Care Health as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in OPCH. Murphy & Mullick Capital Management Corp acquired a new stake in Option Care Health in the 4th quarter worth $26,000. UMB Bank n.a. raised its position in shares of Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after buying an additional 346 shares during the last quarter. Signaturefd LLC raised its position in shares of Option Care Health by 487.9% during the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock valued at $28,000 after buying an additional 1,005 shares during the last quarter. Quadrant Capital Group LLC raised its position in shares of Option Care Health by 172.8% during the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock valued at $40,000 after buying an additional 1,099 shares during the last quarter. Finally, Johnson Financial Group Inc. acquired a new position in shares of Option Care Health during the fourth quarter valued at about $47,000. 98.05% of the stock is owned by institutional investors.

Insider Activity

In other news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares of the company's stock, valued at $1,495,835.24. This represents a 40.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.64% of the stock is owned by insiders.

Option Care Health Price Performance

NASDAQ:OPCH traded down $0.44 during mid-day trading on Thursday, hitting $32.27. The company's stock had a trading volume of 454,287 shares, compared to its average volume of 1,853,630. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The company has a market capitalization of $5.28 billion, a price-to-earnings ratio of 27.11, a P/E/G ratio of 2.30 and a beta of 0.76. The stock has a fifty day moving average of $33.09 and a 200-day moving average of $29.17.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.04. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The firm had revenue of $1.33 billion for the quarter, compared to analysts' expectations of $1.26 billion. During the same period in the prior year, the firm earned $0.26 earnings per share. The company's quarterly revenue was up 16.3% compared to the same quarter last year. As a group, equities analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have recently commented on OPCH shares. JPMorgan Chase & Co. upped their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research report on Thursday, March 6th. JMP Securities reaffirmed a "market outperform" rating and set a $36.00 price objective on shares of Option Care Health in a research report on Tuesday, April 22nd. Barrington Research reaffirmed an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a research report on Wednesday, April 30th. Jefferies Financial Group raised shares of Option Care Health from a "hold" rating to a "buy" rating and upped their price objective for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. Finally, UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their price objective for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. One equities research analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $35.50.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.